# Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds

> **NCT00691002** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 1245 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Calcipotriol plus hydrocortisone (LEO 80190)
- **DRUG:** LEO 80190 Vehicle
- **DRUG:** Hydrocortisone
- **DRUG:** Calcipotriol

## Key facts

- **NCT ID:** NCT00691002
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1245 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00691002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00691002, "Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin Folds". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00691002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*